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We have previously demonstrated that Type I neuronal nitric oxide synthase
(nNOS)-expressing neurons are sleep-active in the cortex of mice, rats, and hamsters.
These neurons are known to be GABAergic, to express Neuropeptide Y (NPY) and, in
rats, to co-express the Substance P (SP) receptor NK1, suggesting a possible role for SP
in sleep/wake regulation. To evaluate the degree of co-expression of nNOS and NK1 in
the cortex among mammals, we used double immunofluorescence for nNOS and NK1
and determined the anatomical distribution in mouse, rat, and squirrel monkey cortex.
Type I nNOS neurons co-expressed NK1 in all three species although the anatomical
distribution within the cortex was species-specific. We then performed in vitro patch
clamp recordings in cortical neurons in mouse and rat slices using the SP conjugate
tetramethylrhodamine-SP (TMR-SP) to identify NK1-expressing cells and evaluated the
effects of SP on these neurons. Bath application of SP (0.03–1μM) resulted in a sustained
increase in firing rate of these neurons; depolarization persisted in the presence of
tetrodotoxin. These results suggest a conserved role for SP in the regulation of cortical
sleep-active neurons in mammals.
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INTRODUCTION
Sleep is homeostatically regulated, such that increasing time
awake causes elevation in sleep pressure. The neurobiological
substrates of this homeostasis remain unclear (Kilduff et al.,
2011). Using Fos immunoreactivity as a neural activity marker, we
recently found that GABAergic cortical interneurons expressing
neuronal nitric oxide synthase (nNOS) are selectively activated
during sleep in three rodent species (Gerashchenko et al., 2008).
Since the proportion of nNOS neurons expressing Fos was corre-
lated with slow wave energy, an electroencephalographic (EEG)
indicator of sleep pressure, we have proposed that these neu-
rons are involved in the regulation or mediation of the home-
ostatic recovery process that occurs during sleep (Kilduff et al.,
2011).
Two morphological types of cortical nNOS neurons have been
identified in primates (Aoki et al., 1993; Lüth et al., 1994). Type
I nNOS neurons have larger somata and show intense labeling
with antisera to nNOS, as well as with histochemical stain-
ing of nicotinamide adenine dinucleotide phosphate diaphorase
(NADPH-d), whereas type II neurons have smaller somata and
show weaker labeling. More recently, both types of nNOS neu-
rons were confirmed in rodents using NADPH-d staining (Pereira
et al., 2000; Freire et al., 2004, 2005) and immunohistochemistry
to nNOS (Yousef et al., 2004; Lee and Jeon, 2005; Cho et al., 2010).
The sleep-active cortical nNOS neurons are intensely labeled for
nNOS and thus correspond to type I cells (Gerashchenko et al.,
2008).
In a detailed classification study of rat cortical interneurons
(Kubota et al., 2011), type I nNOS neurons were found to be
one of the smallest classes of interneurons and a subgroup of
the cells immunoreactive for both neuropeptide Y (NPY) and
somatostatin (SST). This study also confirmed an earlier finding
(Vruwink et al., 2001) that type I nNOS neurons co-express the
Substance P (SP) receptor NK1. These reports imply that corti-
cal SP may act as a modulator of cortical sleep-active neurons. To
date, no data are available about co-expression of nNOS and NK1
in the cortex of other mammals.
SP is one of the most abundant peptides in the central ner-
vous system and has been implicated in a variety of physiological
and pathophysiological processes. Most of the early research
focused on its role in nociception, particularly in the spinal cord
(reviewed by Hill, 2000). More recent research has established
a role for SP in other nervous system functions, such as stress
and addiction (reviews in Ebner and Singewald, 2006; Commons,
2010). However, evidence for a role of SP in sleep/wake regula-
tion is sparse and inconclusive (see Nishino and Fujiki, 2007).
While activation of the NK1 receptor on neurons usually causes
depolarization (Dreifuss and Raggenbass, 1986; Maubach et al.,
1998; Zaninetti and Raggenbass, 2000; Ito et al., 2002; Bailey
et al., 2004; Blomeley and Bracci, 2008; Morozova et al., 2008;
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Paul and Cox, 2010), NK1 activation can also have hyperpolariz-
ing effects (Jafri andWeinreich, 1996). The effects of NK1 agonists
in most cortical areas and on nNOS neurons in particular are
unexplored to this point.
The aims of this study were to identify whether the pres-
ence of the NK1 receptor in type I nNOS neurons generalizes
to other mammals and to determine the effects of SP on cortical
NK1/nNOS neurons. To address these questions, we performed
double immunofluorescence for nNOS and NK1 in mouse, rat,
and squirrel monkey cortical tissue and conducted in vitro patch
clamp recordings of NK1 neurons in cortical slices from mice
and rats.
MATERIALS AND METHODS
ANIMALS
Five male C57BL/six mice (4–5 weeks of age), five male Sprague–
Dawley rats (5–6 months of age), and three squirrel monkeys
(Saimiri sciureus two female, 687 g and 740 g; one male, 908 g;
approximately five-years old) were used for immunofluorescence.
Nine male Sprague–Dawley rats (3–6 weeks of age) and 29
NPY-hrGFP mice [B6.FVB-Tg(Npy-hrGFP)1Lowl/J, JAX® Mice,
Sacramento, CA; 3–6 weeks of age] of both sexes were used
for in vitro recordings. NPY-hrGFP mice express humanized
Renilla green fluorescent protein under control of the mouse
NPY promoter (van den Pol et al., 2009). An additional NPY-
hrGFP mouse was used for nNOS immunofluorescence. Mice
and rats were housed with ad libitum access to food and water
under a 12 h light/dark cycle for at least seven days before
use in an experiment. Squirrel monkeys were purchased from
Worldwide Primates (Miami, FL) and quarantined for onemonth
according to California state regulations. All studies were per-
formed according to guidelines approved by the SRI International
Institutional Animal Care and Use Committee in conformance
with the United States Public Health Service Guidelines on Care
and Use of Animals in Research. Every effort was made to mini-
mize the number of animals utilized in this study and to eliminate
suffering.
IMMUNOFLUORESCENCE
Tissue preparation
Mice and rats were anesthetized with an overdose of euthana-
sia solution (0.1ml and 1ml, respectively, 390mg/ml sodium
pentobarbital and 50mg/ml phenytoin sodium, Beuthanasia-D,
Intervet, Summit, NJ) i.p. and intracardially perfused with hep-
arinized phosphate buffered saline (PBS, 0.01M, pH 7.2–7.4)
followed by 4% paraformaldehyde in PBS. Brains were postfixed
in the fixative overnight at 4◦C. Monkeys were injected with
1.5ml euthanasia solution (390mg/ml sodium pentobarbital and
50mg/ml phenytoin sodium, Euthasol, Henry Schein, Melville,
NY) i.p., followed by 1.5ml/kg of the same solution adminis-
tered intravenously. The brains were rapidly removed, rinsed in
cold PBS, placed in a squirrel monkey brain mold, and cut into
2mm-thick blocks using stainless steel blades. For each animal,
two blocks were immersion fixed in 4% paraformaldehyde in PBS
overnight at 4◦C. The remaining blocks were used for unrelated
studies. All tissue was cryoprotected in 30% sucrose in PBS at 4◦C.
Coronal 40μm sections were cut on a freezing microtome and
stored at –20◦C in 30% ethylene glycol and 20% glycerol in PBS
until use.
Labeling and visualization
All incubations were performed on free-floating sections at room
temperature (RT). From each brain, one anterior and one poste-
rior section were selected. The anterior-posterior levels were +1.1
and−2.3mm from bregma formice (Paxinos and Franklin, 2001)
and +2.04 and −4.44 for rats (Paxinos and Watson, 2007). For
monkeys, the frontal section was anterior of the striatum (frontal
of A15 according to Emmers and Akert (1963) and about section
180 of the squirrel monkey brain atlas at http://brainmuseum.
org) and P0.5 (Emmers and Akert, 1963). For monkeys, only
about half of the anterior section was available for this study. For
two monkeys, this was mainly the superior frontal gyrus; for the
other monkey, it was mainly the inferior frontal gyrus.
Endogenous peroxidase activity was quenched by 15min incu-
bation in 1% H2O2 in PBS. Sections were preincubated for 1 h
in 5% normal donkey serum with 0.3% Triton and 0.1% sodium
azide in PBS. Endogenous biotin was blocked by 15min incuba-
tion in avidin solution followed by 15min incubation in biotin
solution (Vector Laboratories, Burlingame, CA). Incubation in
primary antibody was performed overnight with a cocktail of
mouse anti-nNOS antibody (N2280, Sigma-Aldrich, Milwaukee,
WI) and rabbit anti-NK1 antibody (gift from Prof. R. Shigemoto,
National Institute for Physiological Sciences, Okazaki, Japan).
For immunofluorescence of one NPY-hrGFP mouse, the NK1
antibody was omitted. The concentrations utilized were deter-
mined by titration for optimal labeling for each species and
were 0.25μg/ml anti-NK1 and 180μg/ml anti-nNOS for mouse,
0.1μg/ml anti-NK1 and 180μg/ml anti-nNOS for rat, and
0.5μg/ml anti-NK1 and 450μg/ml anti-nNOS for monkey tis-
sue. As a negative control, the primary antibodies were omitted
on additional sections of each species. nNOS was visualized with
a donkey anti-mouse secondary antibody conjugated to Alexa
Fluor 546 (Invitrogen, Chicago, IL, 1:500, 2 h). NK1 was visual-
ized using a Tyramide Signal Amplification Fluorescein system
(Perkin-Elmer, Los Angeles, CA), preceded by a 2 h incubation
with biotinylated secondary antibody (Jackson ImmunoResearch,
West Grove, PA, 2.6μg/ml for rodents, 1.3μg/ml for monkeys)
and a 2 h incubation with an avidin-biotinylated peroxidase com-
plex (Vector Laboratories, 1:200). Sections were mounted on
glass slides, dehydrated in a graded series of alcohol, cleared
with xylenes, and cover slipped in Depex (Electron Microscopy
Sciences, Hatfield, PA) for permanent mounting (Espada et al.,
2005). Labeled cell profiles in the neocortex and underlying white
matter in one hemisphere of each section were counted at 400×
magnification using Stereoinvestigator software (MBF Bioscience,
Willoston, VT).
In vitro ELECTROPHYSIOLOGY
Slice preparation
Rodents were deeply anesthetized with isofluorane and then
decapitated. Brains were isolated in ice-cold oxygenated high
sucrose solution containing (mM): sucrose 234, KCl 2.5, CaCl2
0.5, NaH2PO4 1.25, MgSO4 10, glucose 11, bubbled with 95%
O2–5% CO2. Coronal brain slices (250μm thickness) of the
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region containing the rostral-most 2mm of the striatum were
cut with a microtome (VT-1000S, Leica, Germany). Slices were
then transferred to an incubation chamber where they were
superfused with physiological bicarbonate solution containing
(mM): NaCl 123, KCl 3, CaCl2 2, NaHCO3 26, glucose 11,
NaH2PO4 1.25, MgCl2 1, bubbled with 95% O2–5% CO2 at
RT (22–24◦C) for at least 1 h before recordings. The osmolar-
ity of these external solutions was checked by a vapor pressure
osmometer (Advanced Instruments, Norwood, MA) and ranged
between 295 and 305mOsmol l−1.
Whole-cell patch clamp recordings
Patch pipettes were prepared from borosilicate capillary glass
(G150F-4, Warner Instruments LLC, Hamden, CT) with a
micropipette puller (P-97, Sutter Instruments, Novato, CA). The
pipettes were routinely filled with a KGlu-internal solution con-
taining (mM): KGluconate 125, KCl 10, MgCl2 1, EGTA 5,
Hepes 10, MgATP 1, NaGTP 0.5, adjusted to pH 7.25 with KOH.
For some experiments, 8mM biocytin was added to the internal
solution for post-hoc characterization of the recorded neurons.
The osmolarity of these internal solutions was between 290 and
305 mOsmol l−1. Pipette resistance measured in the external
solution was 4–8M. The series resistance during recording was
12–48M and was compensated while recording in current-
clamp mode. The reference electrode was an Ag–AgCl pellet
immersed in the bath solution. The liquid junction potential was
estimated to be 15mV and was subtracted from the recorded
membrane potential.
For electrophysiological recordings, a single slice was trans-
ferred to a recording chamber (RC-26G, Warner Instruments
LLC, Hamden, CT) and superfused with the physiological bicar-
bonate solution at RT at a flow rate of 2ml/min. For in vitro iden-
tification of live neurons expressing the NK1 receptor, 50–80 nM
of tetramethylrhodamine conjugated to Substance P (TMR-SP)
from Enzo Life Sciences, NY (Labrakakis and MacDermott, 2003;
Pagliardini et al., 2005; Torsney and MacDermott, 2006) was
added to the bath for 3min (from a 56μM stock solution
in H2O stored at −20◦C) and slices were washed for at least
30min before identification of labeled neurons. Cortical cells
were visualized under an upright microscope (Leica DM LFSA,
Leica Microsystems, Germany) using both infrared-differential
interference contrast (IR-DIC) microscopy and fluorescence
microscopy. Infrared images were acquired via a charge-
coupled device (CCD) camera optimized for infrared wave-
lengths (DAGE-MITI, Michigan City, IN); fluorescence images
were acquired using a digital microscope camera (ProgRes®
MF, JENOPTIK Optical Systems GmbH, Germany). Recording
pipettes were advanced toward individual NPY and/or TMR-SP
fluorescent labeled cells in the slice under positive pressure and,
on contact, tight seals between the pipette and the cell mem-
brane on the order of 1–4G were made by negative pressure.
The membrane patch was then ruptured by suction and mem-
brane potential was monitored in current-clamp mode using a
Multiclamp 700A amplifier (Molecular Devices, Sunnyvale, CA).
Only cells in which the resting membrane potential (Er) was
below −50mV were included in this study. The output volt-
age signal was low-pass filtered at 3 kHz and digitized at 10 kHz.
Data were recorded on a computer through a Digidata 1320A
A/D converter using pCLAMP software version 9.2 (Molecular
Devices, Sunnyvale, CA). Recorded data were processed and plot-
ted usingMatlab R2010b (Mathworks, Natick,MA). For statistical
comparisons, values were compared using analysis of variance
(ANOVA) and the two samples, unpaired t-test with the program
GNUOctave (http://www.gnu.org/software/octave/).
Characterization of recorded neurons at rest and after application
of SP
At the initiation of whole-cell recordings, three different neg-
ative pulses of 1 s were delivered every 2 s in order to obtain
three levels of hyperpolarization. The cell capacitance was deter-
mined by fitting the initial 300ms of the hyperpolarizing pulse
to a single exponential and averaging the three values obtained.
The input resistance (Rin) at each hyperpolarization level was
calculated as the maximal change in voltage obtained within
these 300ms divided by the injected current. Rin in absence of
injected current was calculated by linear regression. Er of the
cells was calculated by averaging 100ms of membrane potential
at rest. 1mM stock solutions of SP in H2O (Sigma Aldrich, St.
Louis, MO) were stored at −20◦C in 0.2ml aliquots. After ver-
ifying that the whole-cell recording was stable, SP was further
diluted in bubbling artificial cerebrospinal fluid (ACSF) to obtain
a final concentration of 0.03–1μM and was applied in the bath
for 30–120 s. In a similar fashion, tetrodotoxin (TTX; Abcam,
Cambridge, MA) was also added to an additional container of
oxygenated ACSF with or without SP at a final concentration of
1μM prior to bath application. With SP in the bath, hyperpolar-
izing pulses (40–50 pA, 200ms duration) were applied to cells at
10 s intervals to monitor Rin over time. SP-induced changes in fir-
ing rate were calculated by averaging the firing rate every 10 s. In
order to detect spikes, traces were high-pass filtered over 100Hz
using a zero-phase forward and reverse digital Butterworth filter
of sixth order. For every filtered trace, an amplitude thresh-
old was manually determined and the onset of the spike was
determined as the crossing of the threshold in the positive
direction.
RESULTS
CORTICAL nNOS NEURONS CO-EXPRESS NK1
In all three species, almost all cortical nNOS neurons were found
to co-express NK1: 90.8% (466 of 513) of nNOS neurons in mice,
98.7% (912 of 914) of nNOS neurons in rats, and 90.9% (1320
of 1452) of nNOS neurons in monkeys were co-labeled for NK1.
In contrast, the proportion of single-labeled NK1 neurons dif-
fered greatly between species. While they were virtually absent in
mice (3.5%, 17 of 483), single-labeled NK1 neurons constituted
a significant population in rats (30.7%, 403 of 1315). In mon-
keys, single-labeled NK1 neurons outnumbered those co-labeled
for nNOS (58.2%, 1834 of 3154).
The distribution of labeled neurons also differed between
species. In mice, nNOS neurons were located mainly in the deep
graymatter (Figures 1A,A’). In rats, nNOS neuronswere scattered
throughout all cortical layers (Figures 1B,B’). In monkeys, nNOS
neurons were concentrated on both sides of the white matter-gray
matter border (Figures 1C,C’). Single-labeled NK1 neurons were
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FIGURE 1 | Distribution of nNOS and NK1 cells in the neocortex of
three mammalian species. In mice (A,A’), virtually all cells were
double-labeled for nNOS and NK1 (orange) and were most abundant in
deep gray matter. Neurons single-labeled for nNOS (red) or NK1 (green)
were virtually absent. In rats (B,B’), double-labeled neurons were
scattered throughout the cortex and underlying white matter; single-labeled
nNOS neurons were virtually absent. Neurons single-labeled for NK1 were
concentrated in superficial layers. In monkeys (C,C’), double-labeled
neurons were most abundant in the deep gray matter and the
underlying white matter and single-labeled nNOS neurons were rare.
Neurons single-labeled for NK1 were concentrated in deep gray matter.
Labeled neurons were more abundant in gyri than in sulci. A, B, and C are
anterior sections, A’, B’, and C’ are posterior sections. Scale bars denote
2mm.
concentrated in the superficial gray matter in rats (Figures 1B,B’)
and deep gray matter in monkeys (Figures 1C,C’). In mon-
keys, both cell types were more abundant in gyri than in sulci
(Figure 1C’).
In all species, nNOS neurons showed a variable dendritic mor-
phology with two or more primary dendrites (Figure 2). We
observed some variability in cell size, with some neurons exhibit-
ing exceptionally large somata. In rats and monkeys, single-
labeled NK1 neurons were found to have a different morphology
than those co-labeled for nNOS. In rats, single-labeled neurons
were noticeably less intensely labeled and mostly smaller than
double-labeled cells (Figure 2B). In monkeys, neurogliaform-like
morphology with a round or oval soma and highly arborized
short dendrites were the most distinctive characteristics of single-
labeled NK1 neurons (Figure 2D). These cells were also often less
intensely labeled and smaller than the double-labeled neurons
(Figure 2C). In contrast, single-labeled nNOS neurons did not
show apparent morphological differences from double-labeled
neurons in any of the three species.
IDENTIFICATION OF SP-RESPONSIVE NEURONS In vitro
Since strongly immunoreactive cortical nNOS cells are a sub-
group of NPY neurons in rats and mice (Tomioka et al., 2005;
Gerashchenko et al., 2008; Kubota et al., 2011) and are concen-
trated in infragranular layers in mice, we initially targeted NPY
neurons in infragranular layers of NPY-hrGFP mice in search of
nNOS/NK1 neurons. However, only 16% (6 of 38) of neurons
recorded in this manner were affected by application of 0.3–1μM
of SP in the bath. The low proportion of GFP-expressing neu-
rons immunoreactive for nNOS in NPY-hrGFPmice is illustrated
in Figure 3. Given the high degree of co-expression of nNOS
and NK1 across species demonstrated above, we therefore used
the NK1 ligand TMR-SP to increase the yield of nNOS neu-
rons among NPY cells recorded in vitro in NPY-hrGFP mice
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FIGURE 2 | Colocalization of NK1 and nNOS. In mice (A,A’), virtually all
neurons were double-labeled (arrows) for NK1 (green, top panels) and nNOS
(red, bottom panels). In rats (B,B’), we found both double-labeled neurons
and neurons labeled for NK1 only (arrowheads). Neurons staining for NK1
alone had smaller somata and less intense labeling. Portions of the
micrographs containing the weakly labeled NK1 neurons are displayed in the
insets (yellow squares) with enhanced brightness to enable visibility. Note
the absence of nNOS labeling in these neurons in B’. In monkeys (C,C’),
double-labeled neurons had a dendritic arborization pattern similar to that of
the other species, whereas neurons single-labeled for NK1 had round somata
surrounded by short, thin, highly arborized dendrites. Fluorescent blood
vessels are visible because monkeys were not perfused before fixation.
The punctate pattern of NK1 labeling in C and the bottom cell in A is typical
for NK1 endocytosis upon ligand binding. (D) A single-labeled NK1 neuron of
monkey cortex at higher magnification for better visibility of the morphology.
Note the highly arborized, short dendrites. Scale bars denote 50μm.
Micrographs were taken as monochrome pictures and pseudocolored for
representation.
FIGURE 3 | In vitro identification of NK1+ neurons in the cortex of
NPY-hrGFP transgenic mice. (A) Visualization of NPY neurons in the cortex
of NPY-hrGFP transgenic mice. This 40μm section was processed for nNOS
immunofluorescence. (B) nNOS-immunoreactive cells in the same section
illustrated in A. nNOS neurons are located mainly in layer 6, adjacent to the
white matter. Arrows in A and B denote neurons that show both green (GFP)
and red (nNOS) fluorescence. Note the small proportion of NPY neurons
co-expressing nNOS. (C) In vitro visualization of an NPY neuron for targeted
patching. (D) Same cell as C illuminated with green light after a 3-min bath
application of 56 nM TMR-SP followed by a 30min wash. Micrographs in C
and D are pseudocolored to resemble the original colors. Scale bar denotes
200μm in A; 50μm in C.
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and to identify these neurons also in rats. A 3-min bath appli-
cation of TMR-SP (56 nM) was sufficient to label neurons for
more than 2 h. Since TMR-SP might produce effects in NK1
neurons comparable to SP itself, at least 30min elapsed between
TMR-SP application and initiation of a search for labeled cells
for subsequent patching. Figure 3C shows a healthy NPY neuron
visualized in vitro. After confirming the viability of the neuron
by visualizing it under IR-DIC, the blue excitation was replaced
by green illumination, thereby enabling visualization of TMR-SP-
labeled neurons (Figure 3D). TMR-SP fluorescence was dim and
could only be detected at 400× magnification. GFP fluorescence
from NPY neurons could be detected at 50× magnification and
was, therefore, used to aid identification of TMR-SP-labeled neu-
rons in mice. No significant differences in Er , Rin, capacitance, or
time constant (τ) were observed when cells identified by TMR-SP
(N = 8) were compared to SP-responsive NPY-hrGFP neurons
that had not been exposed to TMR-SP (N = 6). Consequently,
all SP-responsive neurons were considered as a single group for
statistical analysis.
SP DIRECTLY DEPOLARIZES SP-RESPONSIVE NEURONS IN MICE
AND RATS
To evaluate the effect of SP on neuronal firing rate, mouse
cortical neurons were initially hyperpolarized with 0–10 pA to
reduce spontaneous firing. Application of 0.03–1μM SP induced
on average (all values correspond to mean ± standard devia-
tion) an increase in firing rate of 10.2 ± 4.9 spikes/s (N = 11).
Blockade of voltage-dependent sodium channels by >5min of
bath application of 1μM TTX was tested in seven cells. Addition
of 0.03–0.3μM SP induced a depolarization of 11.9 ± 4.6mV
(N = 7). SP-induced depolarization in the presence of TTX was
found in all cells tested, indicating that the action of SP is most
likely direct. Figure 4A shows an example of SP-induced depo-
larization of a neuron in mouse cortex. Figure 4B shows the
membrane potential of a different neuron under TTX and its
response to two successive applications of SP. The large vari-
ability observed in both the amplitude and the duration of the
SP-induced depolarization for a given SP concentration precludes
the elaboration of a dose response curve at the present time.
Similar results were obtained for TMR-SP fluorescent neurons
selected for recording in rat cortical slices, where bath appli-
cation of 0.1–0.3μM SP induced an increase of 5 ± 2 spikes/s
(N = 9) in firing rate and, under 1μM TTX, a depolarization
of 8.1 ± 3.6mV (N = 5 out of 5 neurons tested). Figure 4C
shows an example of an SP-induced increase in firing rate of a
TMR-SP-responsive cell in a rat cortical slice. Figure 4D shows
a different neuron exhibiting a prolonged depolarization after
1min application of SP.
SP-RESPONSIVE NEURONS HAVE DIFFERENT ELECTRICAL
PROPERTIES THAN NON-SP-RESPONSIVE CELLS
By visual inspection of NPY neurons in mice, we did not
observe a clear morphological difference that allowed distinc-
tion between SP-responsive (NK1+) NPY cells and NPY neurons
that did not respond to SP (NK1−). However, during whole-
cell recordings, striking differences were found in Er , Rin, and
τ of these cells. Figure 5A shows an example of the membrane
potential of an NK1+ neuron (orange trace) and an NK1−
cell (black trace) during 1 s current pulses of −25, −50, and
−75 pA. Although both cells were injected with the same three
FIGURE 4 | SP depolarizes cortical NK1+ neurons. (A) Application of
50 nM SP to the bath depolarizes an NK1+ neuron in the mouse cortex and
generates an increase in firing rate that persists for about 10min.
(B) Successive applications of 50 nM SP elicit similar responses during
blockade of voltage-dependent Na+ channels with TTX. (C) SP increases the
firing rate of cortical NK1+ neurons in the rat. (D) Under TTX blockade, rat
NK1+ cortical neurons can be depolarized for a prolonged period despite the
short duration of SP bath application.
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FIGURE 5 | Electrophysiological characteristics of NPY neurons
recorded in cortical slices from NPY-hrGFP transgenic mice that are
either NK1+ (N = 14) or NK1− (N = 31). (A) Typical single trials of the
membrane potential of an NK1+ neuron (orange) and an NK1− neuron
(black) in response to hyperpolarizing current injections showing a large
difference in time constant (indicated by dotted arrows) and resting
potential. Right inset depicts the injected currents for both neurons.
(B) Mean and standard error of the membrane potential at rest (Er ) for all
recorded NK1+ and NK1− cells. (C) Mean and standard error of the input
resistance at rest (Rin) for all recorded NK1+ and NK1− neurons. (D) Mean
and standard error of the time constant (τ, calculated as the product
between input resistance and capacitance) for all cells where at least three
steps of current were injected. The differences between NK1+ and NK1−
were highly significant in all three cases (p < 3 × 10−6).
levels of current, the larger Rin of the NK1+ cell resulted in a
greater change in membrane potential for a given amount of
current injected and a longer τ (40ms for the highest current
injected, compared to τ = 14ms for the NK1− cell). One-way
ANOVAs revealed that Er , Rin, and τ were significantly differ-
ent between mouse NK1+, mouse NK1−, and rat NK1+ neu-
rons [F(2, 51) = 35.98, p< 2 × 10−10, F(2, 51) = 12.58, p< 4 ×
10−5; F(2, 33) = 31.21, p< 3 × 10−8, respectively]. Post-hoc com-
parisons were performed using t-tests with Bonferroni-adjusted
alpha levels of 0.017 (0.05/3). Figure 5B illustrates that mouse
NK1+ cells (Er = −66.9 ± 5.9mV, N = 14) were more depo-
larized at rest than NK1− cells (Er = −77 ± 4.4mV, N = 31),
t(43) = 6.53, p< 6 × 10−8. Figure 5C illustrates that Rin also dif-
fered between mouse NK1+ cells (476 ± 192M, N = 14) and
NK1− cells (241 ± 101M,N = 31), t(43) = 5.42, p< 3 × 10−6;
and Figure 5D illustrates that τ was longer for mouse NK1+
cells (35.2± 7.4ms, N = 13) than for NK1− cells (13 ± 4.9ms,
N = 14), t(23) = 9.24, p< 2× 10−9. The electrical parameters of
rat NK1+ neurons (Er = −63.1± 6.3mV, Rin = 332± 195M,
and τ = 31± 11ms) were not statistically different from mouse
NK1+ neurons [t(21) = 1.45, p = 0.16; t(21) = 1.74, p = 0.10;
t(20) = 1.12, p = 0.28, respectively]. However, Er and τ of rat
NK1+ neurons differed from that of mouse mouse NK1−
neurons [t(38) = 7.60, p< 4 × 10−9; t(21) = 5.35, p< 3 × 10−5,
respectively].
DISCUSSION
In the three species investigated here, virtually all cortical nNOS
neurons were co-labeled for NK1 while the proportion of single-
labeled NK1 neurons varied among species. In vitro patch clamp
recordings showed that 0.03–1μM SP elicited persistent depolar-
ization and a robust increase in firing rate of putative nNOS neu-
rons in mice and rats. These results suggest that SP can activate
cortical nNOS neurons across species. Combined with our pre-
vious findings that cortical nNOS neurons are sleep-active, these
results suggest a possible role for SP in sleep regulation.
TYPE I AND TYPE II nNOS NEURONS
We assume that all nNOS neurons we detected were type I
because their morphology and distribution matches that of pre-
vious reports for the species investigated here (e.g., Wiencken
and Casagrande, 2000; Freire et al., 2004, 2005). Our nNOS anti-
body failed to detect the weakly labeled type II nNOS neurons
that have previously been reported in mice (Freire et al., 2005;
Lee and Jeon, 2005), rats (Freire et al., 2004; Yousef et al., 2004;
Cho et al., 2010; Kubota et al., 2011), and squirrel monkeys
(Franca et al., 1997; Wiencken and Casagrande, 2000). Our anti-
body is raised against an N-terminal fragment of rat nNOS and,
therefore, likely detects only the most abundant alpha splice vari-
ant (Mardsen et al., 2011). Using a different N-terminal-directed
antibody, Vruwink et al. (2001) also failed to report type II nNOS
neurons in rats. Thus, it is possible that type II nNOS neu-
rons mainly express an alternative splice variant, resulting in our
inability to detect such cells in the present study. In support of that
notion, Eliasson et al. (1997) report immunolabeling of nNOS in
absence of nNOS-alpha in the cortex to be restricted to soma and
proximal dendrites, which is typical for type II neurons.
SINGLE-LABELED NK1 NEURONS
The proportion of neurons immunoreactive for NK1 but not for
nNOS that we found in rats (30.7%, 403 of 1315) was similar to
that reported by Vruwink et al. (26.4%, 174 of 659). However,
Kaneko et al. (1994) reported a much higher number of weakly
labeled NK1 neurons (84.1%, 328 of 390), with the number of
intensely labeled NK1 neurons per section being comparable to
NK1/nNOS neurons in the present study. Since the immunoflu-
orescence protocols in our study were optimized for detection
of intense NK1 neurons, it is possible that some weakly labeled
NK1 neurons in rats were below our detection limit. However,
Kaneko et al. reported a very similar distribution of weakly labeled
NK1 neurons in the cortex as we do, suggesting that they likely
observed the same cell type.
Weakly labeled NK1 neurons share several characteristics with
type II nNOS neurons. For example, both are concentrated in
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superficial layers (Freire et al., 2004; Cho et al., 2010) and co-
express parvalbumin but not SST in rats (Vruwink et al., 2001;
Kubota et al., 2011). Like the single-labeled NK1 neurons in our
study, type II nNOS neurons have a neurogliaform-like morphol-
ogy in primates (Smiley et al., 2000). However, squirrel monkey
type II nNOS neurons are distributed throughout all cortical
laminae with highest abundance in layers II/III (Franca et al.,
1997; Wiencken and Casagrande, 2000). In contrast, we found
the single-labeled NK1 neurons to be concentrated in deep gray
matter. Kubota et al. (2011) found a small number of supragran-
ular NK1 neurons in rats that did not co-label for SST, and thus
probably correspond to the same cell type. However, Kubota et al.
did not report whether these cells were nNOS positive. Taken
together, these results suggest that the weakly labeled NK1 neu-
rons and type II nNOS neurons could be overlapping populations
in rats and monkeys. More work will be needed to test this
possibility.
Rats and primates used for histology in this study were young
adults (sexual maturity develops around six weeks and three
years, respectively), whereas mice were around onset of sexual
maturity. Although maturation of type I nNOS neurons appears
to precede sexual maturity in rodents (Chung et al., 2004; Eto
et al., 2010), no such data are available for weakly labeled corti-
cal NK1 neurons. Ontogenetic studies will be needed to evaluate
if differences in cortical maturation contributed to the differences
in distribution of weakly labeled NK1 neurons reported here.
In vitro RECORDINGS
In both species investigated, bath application of SP elicited TTX-
insensitive depolarization of SP-responsive neurons. These obser-
vations are in agreement with the finding that NK1 agonists elicit
action potentials in putative interneurons and increase the fre-
quency of inhibitory postsynaptic currents in principal neurons
in the rat entorhinal cortex (Stacey et al., 2002). The depolariza-
tion in response to SP that we observed lasted several minutes,
similar to findings in other electrophysiological studies usingNK1
agonists (Dreifuss and Raggenbass, 1986; Maubach et al., 1998;
Zaninetti and Raggenbass, 2000; Ito et al., 2002; Bailey et al.,
2004; Blomeley and Bracci, 2008; Morozova et al., 2008; Paul and
Cox, 2010). Determination of the type of channels involved in the
reported neuronal activation was beyond the scope of the present
study.
Our findings that SP-responsive neurons have a higher rest-
ing membrane potential, a higher input resistance, and a longer
time constant than other NPY neurons suggest the possibility of a
specialized function of this population. This difference is under-
lined by the finding that electrical properties of mouse NK1+
neurons were more similar to rat NK1+ neurons than to mouse
NK1− neurons. A detailed comparison of morphology and mem-
brane protein composition might shed light on the source of this
significant difference.
The virtually complete overlap of nNOS and NK1 expression
in mice implies that the neurons recorded in vitro were type I
nNOS neurons. Labeling with TMR-SP in live tissue was reliable
but faint, requiring exposure times of several seconds in order to
obtain a clear picture with our fluorescent camera; this proba-
bly caused a detection bias toward more intensely labeled cells. In
the rat, the characteristic weak immunolabeling for NK1 in the
single-labeled NK1 neurons suggests that these cells express less
receptor and likely show even fainter labeling with TMR-SP, mak-
ing them unlikely to be detected. For the same reasons we do not
expect to have detected binding to the low-affinity SP receptors
NK2 and NK3, which are also present in the cortex (Mileusnic
et al., 1999; Saffroy et al., 2003; Duarte et al., 2006). Therefore, we
assume that most, if not all, cells that we recorded in rats were of
the type that showed intense NK1 immunolabeling and thus were
likely type I nNOS neurons.
The large variation in the response to SP that hindered the
elaboration of a dose response curve likely reflects variabil-
ity within the population of intense NK1 neurons rather than
between intense ones and weak ones. This conclusion is consis-
tent with the previously described heterogeneity of expression
of calcium binding proteins among type I nNOS neurons
(Pasumarthi et al., 2010, and references therein). It is currently
unclear whether this heterogeneity reflects a further functional
subdivision of type I nNOS neurons or rather differences in neu-
ronal states. A larger number of recordings are needed to address
this question and will be the subject of a subsequent study.
SOURCE OF CORTICAL SP
Despite the direct effects of SP on NK1 neurons described here,
there is a spatial mismatch between the NK1 receptor and SPergic
axon terminals in the cortex (Liu et al., 1994; Vruwink et al., 2001;
Wolansky et al., 2007). Cortical SPergic neurons are GABAergic
and about 70% of this population co-express Parvalbumin in the
rat (Kaneko et al., 1998; Vruwink et al., 2001). These neurons also
co-express the NO receptor soluble guanylyl cyclase (Vruwink
et al., 2001). Therefore, it was suggested that SPergic neurons
release SP as a volume transmitter and are, in turn, modulated
by NO released from the NK1/nNOS neurons, forming a non-
synaptic cortical feedback loop (Vruwink et al., 2001). However,
SPergic afferents to the cortex have also been found to originate
from the laterodorsal tegmental nucleus (Vincent et al., 1983)
and it cannot be excluded that other subcortical sources exist
(see Wolansky et al., 2007). Furthermore, NK1 is the preferred
receptor not only for SP, but also for the more recently discovered
tachykinins hemokinin-1 and endokinin A and B (Page, 2004).
The ligands neurokinin A and B can also activate the NK1 recep-
tor, although with lower affinity (Ingi et al., 1991). Clearly, more
work is needed to identify the source of NK1 activation of cortical
nNOS neurons in vivo.
PHYSIOLOGICAL FUNCTION
Type I nNOS neurons are sleep-active in mice, rats, and hamsters
(Gerashchenko et al., 2008; Pasumarthi et al., 2010). This unusual
activation pattern has not yet been tested in primates. However,
the similar dendritic and axonal morphology of these neurons in
rodents (Tomioka et al., 2005), cats (Higo et al., 2007, 2009), and
primates (Tomioka and Rockland, 2007) and the conserved co-
expression of NPY and SST (Smiley et al., 2000; Kubota et al.,
2011), as well as NK1 receptors (shown in this study), suggest that
this neuronal population has a conserved function in mammals.
The similar electrophysiological properties we found in mice and
rats support this notion.
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The potential involvement of SP in sleep regulation has been
little studied to date. Local injection of SP into the ventro-
lateral preoptic area (VLPO) facilitated sleep in mice (Zhang
et al., 2004). In contrast, intracerebroventricular SP injections
disturbed sleep in mice (Andersen et al., 2006) and intravenous
injection disturbed sleep in humans (Lieb et al., 2002). These
results indicate that wake-promoting neurons in one or more
subcortical areas expressing NK1 (Nakaya et al., 1994) such as
the locus coeruleus, the dorsal raphe nucleus, or the choliner-
gic basal forebrain (Hahn and Bannon, 1999; Chen et al., 2001;
Lacoste et al., 2006) override activation of sleep-promoting neu-
rons in the VLPO (and possibly cortex) after systemic injection.
SP depolarizes noradrenergic neurons of the locus coeruleus
in vitro (Cheeseman et al., 1983) and increased SP levels in this
nucleus have been linked to increased release of noradrenaline in
the prefrontal cortex of rats (Ebner and Singewald, 2007). SP has
been reported to excite (Liu et al., 2002) or inhibit (Valentino
et al., 2003) dorsal raphe neurons, and to increase (Gradin et al.,
1992) or decrease (Guiard et al., 2007) serotonin release. This
was suggested to reflect region dependence of SP effects within
the nucleus (Valentino et al., 2003; Guiard et al., 2007). A sleep-
disturbing effect of systemic applications of SP is also in agree-
ment with reports that such application induces stress and fear
responses (reviewed in Ebner and Singewald, 2006).
NK1 desensitizes upon prolonged stimulation with SP and
resensitization takes about 30min in neurons (McConalogue
et al., 1998). Given the long timescale of NK1 desensitization and
our finding that the activating effects of a brief exposure to SP
can persist for several minutes, the cortical SP/NK1 system would
be suitable to regulate slow aspects of sleep/wake regulation, such
as the buildup or decay of sleep need. This idea is supported by
the finding that cortical mRNA levels of the gene encoding SP are
upregulated by sleep deprivation in mice (Martinowich et al.,
2011).
POTENTIAL RELEVANCE FOR PATHOLOGIES
Given the presumed ability of nNOS/NK1 neurons to elicit
widespread cortical inhibition by long range axons and release of
the volume transmitter NO (Kilduff et al., 2011; also see Shlosberg
et al., 2012), it is conceivable that an imbalance in their reg-
ulation could lead to imbalance in overall cortical excitability.
In agreement with that view, NK1 agonists exerted a powerful
antiepileptic effect in a slice preparation of the entorhinal cortex
(Maubach et al., 1998). Alterations in the gene coding for NK1
have been linked to attention deficit hyperactivity disorder in
humans (Yan et al., 2010). Pharmacological or genetic disruption
of NK1 also induces hyperactivity in mice (Herpfer et al., 2005;
Yan et al., 2010); reduced activation of cortical nNOS neurons
could contribute to that phenotype. Depressed patients, on the
other hand, show increased levels of SP in the cerebrospinal fluid
(Geracioti et al., 2006). NK1 levels in the orbitofrontal cortex
of depressed patients are decreased (Stockmeier et al., 2002),
which might be a compensatory response to increased levels of
SP. Similarly, frontal cortical SP levels are increased in different
animal models of depression (Husum et al., 2001; Roche et al.,
2012). Abnormally high cortical SP levels might be linked to a
depressive phenotype by excitation of inhibitory cortical nNOS
neurons.
CONCLUSION
Cortical type I nNOS neurons in all three species investigated
showed an almost complete co-expression of the NK1 receptor.
SP application elicited a direct and persistent activation of puta-
tive nNOS neurons in vitro. Cortical release of SP may be involved
in aspects of sleep/wake regulation mediated by sleep-active type
I nNOS neurons. Type I nNOS neurons might also be involved
in mediating psychopathologies of SP/NK1 imbalances, such as
attention deficit hyperactivity disorder or depression.
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